Files and links (1)
Published, Version of Record (VoR)CC BY V4.0, Open
Journal article
Development of New Deep Venous Thrombosis While on Apixaban
Case reports in cardiology, v 2017, pp 1-3
01 Jan 2017
PMID: 28713598
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
The efficacy of novel oral anticoagulants (NOACs) in preventing deep venous thrombosis (DVT) has been established in large multicenter trials. Predictable pharmacokinetics, avoidance of routine laboratory monitoring, and lesser drug interactions have made NOACs safer andmore tolerable treatment option in comparison to warfarin. However, cases of treatment failuremainly due to interindividual variation in plasma drug levels can be seen rarely. In this report we describe a case of acute DVT of right lower extremity in a patient who was on apixaban for prevention of venous thromboembolism (VTE) due to underlying nonvalvular atrial fibrillation (NVAF).
Metrics
5 Record Views
Details
- Title
- Development of New Deep Venous Thrombosis While on Apixaban
- Creators
- Munish Sharma - Easton HospitalSabarina Ramanathan - Easton HospitalKoroush Khalighi - Drexel University
- Publication Details
- Case reports in cardiology, v 2017, pp 1-3
- Publisher
- Hindawi Publishing Group
- Number of pages
- 3
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Medicine (Graduate)
- Web of Science ID
- WOS:000403869200001
- Other Identifier
- 991019168632704721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Cardiac & Cardiovascular Systems